Directors’ Deals: US deal sparks Fever-Tree buying
The agreement has been structured as a licence deal, with Fever-Tree receiving royalty fees based on its share of the profit generated in the US (with minimum payments guaranteed for five years).
Molson Coors' CMO breaks down the 'MUSCLE' framework she says makes a great Super Bowl ad
From a viral stunt to chilled face rollers, Coors Light has been laying the groundwork for its "Case of the Mondays" Super ...
Molson Coors price target lowered to $60 from $68 at Evercore ISI
Evercore ISI lowered the firm’s price target on Molson Coors (TAP) to $60 from $68 and keeps an Outperform rating on the shares ahead of the ...
Molson Coors Beverage Co. Cl B stock outperforms competitors on strong trading day
This was the stock's second consecutive day of gains.